AzTrials
AzTrials

Inguinal HerniaNCT04792164

Effect of Ultra-Sound Guided Pre-emptive Nerve Block on Post-operative Pain Following Open Inguinal Hernia Repair.

A study testing Ultra sound guided nerve block and Usual infiltration in people with Inguinal Hernia, run by Imam Abdulrahman Bin Faisal University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A hernia occurs when an organ 'like intestines' or fatty tissue protrude through a weak point in muscle or connective tissue and one of the most common types of hernia is inguinal. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Inguinal Hernia
What is being tested?
Ultra sound guided nerve block and Usual infiltration
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
136 participants
Where
No sites listed yet
Study dates
1 Dec 2021to 29 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who underwent elective inguinal hernia repair (will consider the hernia size).
  • Age from 18-70. (70 with no other comorbiditeis)
  • Their ASA score 1,2 or 3 (American Society of Anesthesia)
  • General Anesthesia.
  • Open inguinal hernia repair.

Who cannot join

  • All emergency inguinal hernia repair and recurrent hernia.
  • Children and pregnant women.
  • Patients having regional anesthesia. (Spinal/Local).
  • Laparoscopic inguinal hernia.

Trial locations and contacts

No sites are listed yet.

About this study

Official title: Effect of Ultra-Sound Guided Pre-emptive Nerve Block on Post-operative Pain Following Open Inguinal Hernia Repair: Randomised Control Trial

A hernia occurs when an organ 'like intestines' or fatty tissue protrude through a weak point in muscle or connective tissue and one of the most common types of hernia is inguinal. Inguinal hernia defined as a bulge in the inguinal region or scrotum, may be accompanied by dull or burning pain, which worsens by exercise or cough. There are 2 types of inguinal hernia: direct and indirect. Direct inguinal hernia occurs because of a defect or weakness in the transversalis fascia area of the Hesselbach triangle. On the other hand, the indirect inguinal hernia which is the most common inguinal hernia follows the tract of inguinal canal and result from a persistent processus vaginalis.

Immediate pain after inguinal herniorrhaphy delays the ambulation which leads to delay in the hospital discharge. Besides that, is the chronic pain that affect 50% of patients which is an important issue that needs to be dealt with.

Our aim of this study, is to compare between postoperative period in the patients who received US guided nerve block and in patients who received infiltration only before open inguinal hernia repair, and to show that pre-emptive local anaesthesia will result in better pain control, less postoperative complication, earlier mobilisation, earlier recovery and less analgesia consumption by patients.

Read the detailed description

In this study our aim in detail is to:

  1. Asses the outcomes (early postoperative pain management in day case "day 1,2,3, 30 and 3 month and 6 month" , length of hospital stay, analgesia consumption، recovery to work, driving and usual activity) of the US guided nerve block in patients who underwent inguinal hernia repair comparing to patient who received only skin infiltration.
  2. Evaluate the advantages of the US guided nerve block in postoperative inguinal hernia repair patients.
  3. Demonstrate its compatibly as a one day procedure (less length of hospital stay), with earlier return to work and driving and recovery in general.
  4. Compare our result with other international studies result.

Study in details:

it is Randomised Control Trial, Double blinded (patients and recruiter), study will be conducted in King Fahd University Hospital, Khobar, Eastern Province, Saudi Arabia. It contains 2 Arms ,Two Parallel groups. The experimental group will receive US guided nerve block and the control group will receive usual infiltration. Lidocaine+ Marcaine will be used in both group with same concentration (1%+.25%). The random allocation will be done using simple random allocation with a help of the following software (random.org).

Will compare the two groups regarding, a questionary with visual analogue will be distributed and data will be collected by recruiters regarding pain scale, length of hospital stay, return to work, return to driving and usual activity, and analgesia consumption post operative, all in day 1,2,3,4,30,3 month and 6 month post operatives (details in outcome section).

We are expecting to have a reduction in pain score from severe to moderate, about 20% in experimental group, and reducing the length of hospital stay from 1-2 days to one day procedure. And reduction in consumption of Analgesia postoperative.

our sample size will be 134 with a power of 80% and an effect size of 0.5, will include all patients who will have inguinal hernia repair and meet our inclusion criteria, in period of 12-18 months starting after obtaining of IRB approval.

  • Inclusion criteria:
  1. Patients who underwent elective inguinal hernia repair (will consider the hernia size).
  2. Age from 18-70.
  3. Their ASA score 1,2 or 3 (American Society of Anesthesia)
  4. Operation under general anaesthesia.
  5. Open inguinal hernia repair.
  • Exclusion criteria:
  1. All emergency inguinal hernia repair and recurrent hernia.
  2. Children and pregnant women.
  3. Patients having regional anaesthesia. (Spinal/Local).
  4. Laparoscopic inguinal hernia.

Data Management and analysis plan:

  • SPSS latest version will be used for data analysis.
  • Summary statistic will be obtained as frequency, and percentage for qualitative data, and means, medians and standard deviations from continuous variables.
  • Analysis will be done by epidemiologist and biostatistician.

Ethical Considerations:

  • Our study does not have any physical, psychological, social, legal, economic risk.
  • The study will be reviewed by IRB, ethics committee; then the approval will be obtained.
  • Written approval will be obtained from the patients prior to the procedure.
  • Preemptive analgesia and infiltration are usually used in our practice and aim to compare.
Conditions
Inguinal Hernia
Being tested
Ultra sound guided nerve block, Usual infiltration
Medical subject headings
Hernia, Inguinal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultra sound guided nerve blockProcedure or surgery

    Ultra sound guided nerve block by lidocaine before open inguinal hernia repair.

  • Usual infiltrationProcedure or surgery

    Usual infiltration by lidocaine before open inguinal hernia repair.

Study groups in NCT04792164
Study groupRoleWhat they receive
The experimental group will receive US guided nerve blockExperimentalThe experimental group will receive US guided nerve block by lidocaine before open inguinal hernia repair.
Receives: Procedure: Ultra sound guided nerve block
The control group will receive usual infiltrationOtherThe control group will receive usual infiltration by lidocaine before open inguinal hernia repair.
Receives: Procedure: Usual infiltration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Scale (from 1 to 10) 1 is the minimum and 10 the maximum pain severity.

    Assessment of pain scale post operative, lower score mean a better outcome.

    Measured: Day 1 postoperative.

  2. Pain Scale (from 1 to 10) 1 is the minimum and 10 the maximum pain severity.

    Assessment of pain scale post operative, lower score mean a better outcome.

    Measured: Day 2 postoperative.

  3. Pain Scale (from 1 to 10) 1 is the minimum and 10 the maximum pain severity.

    Assessment of pain scale post operative, lower score mean a better outcome.

    Measured: Day 3 postoperative.

  4. Pain Scale (from 1 to 10) 1 is the minimum and 10 the maximum pain severity.

    Assessment of pain scale post operative, lower score mean a better outcome.

    Measured: Day 4 postoperative.

  5. Pain Scale (from 1 to 10) 1 is the minimum and 10 the maximum pain severity.

    Assessment of pain scale post operative, lower score mean a better outcome.

    Measured: Day 30 postoperative.

  6. Pain Scale (from 1 to 10) 1 is the minimum and 10 the maximum pain severity.

    Assessment of pain scale post operative, lower score mean a better outcome.

    Measured: 3 month postoperative for chronic pain.

  7. Pain Scale (from 1 to 10) 1 is the minimum and 10 the maximum pain severity.

    Assessment of pain scale post operative, lower score mean a better outcome.

    Measured: 6 month postoperative for chronic pain.

  8. Assessment of early mobilisation.

    When the patient started to mobilise? assessed by monitoring the patients postoperative and record when he started to mobilise.

    Measured: Day 1 postoperative period.

  9. Assessment of early mobilisation.

    When the patient started to mobilise? assessed by monitoring the patients postoperative and record when he started to mobilise.

    Measured: Day 2 postoperative period.

  10. Assessment of early mobilisation.

    When the patient started to mobilise? assessed by monitoring the patients postoperative and record when he started to mobilise.

    Measured: Day 3 postoperative period.

  11. Retain to driving (how many days between surgery and patient back to dive)

    When the patient back to drive his car? assessed by monitoring the patients postoperative and record when he started to drive the car again.

    Measured: Postoperative period up to 8 weeks.

  12. Retain to work (how many days between surgery and patient back to his work)

    When the patient back to his work or usual activity? assessed by monitoring the patients postoperative and record when he started to work again.

    Measured: Postoperative period up to 8 weeks.

  13. Length of hospital stay (in days).

    Length of hospital stay post open inguinal hernia repair ( how many days patient spend in the hospital postoperative).

    Measured: immediately after the surgery until patient discharged.

  14. Frequency of analgesia consumption postoperative.

    Analgesia consumption by patient postoperative (How frequent patient taking analgesia postoperative).

    Measured: Day 1 postoperative.

  15. Frequency of analgesia consumption postoperative.

    Analgesia consumption by patient postoperative (How frequent patient taking analgesia postoperative).

    Measured: Day 2 postoperative.

  16. Frequency of analgesia consumption postoperative.

    Analgesia consumption by patient postoperative (How frequent patient taking analgesia postoperative).

    Measured: Day 3 postoperative.

  17. Frequency of analgesia consumption postoperative.

    Analgesia consumption by patient postoperative (How frequent patient taking analgesia postoperative).

    Measured: Day 4 postoperative.

  18. Frequency of analgesia consumption postoperative.

    Analgesia consumption by patient postoperative (How frequent patient taking analgesia postoperative).

    Measured: Day 5 postoperative.

  19. Frequency of analgesia consumption postoperative.

    Analgesia consumption by patient postoperative (How frequent patient taking analgesia postoperative).

    Measured: Day 6 postoperative.

  20. Frequency of analgesia consumption postoperative.

    Analgesia consumption by patient postoperative (How frequent patient taking analgesia postoperative).

    Measured: Day 7 postoperative.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Mar 2021
  2. Study start1 Dec 2021 (estimated)
  3. Primary completion29 Dec 2022 (estimated)
  4. Study completion29 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
2 Arms Arm1) The experimental group will receive US guided nerve block by Lidocaine+Marcaine concentration (1%+.25%). Arm2) The control group will receive usual infiltration by Lidocaine+Marcaine concentration (1%+.25%).
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
136 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04792164
Sponsor's protocol ID
USG-PENB-IHR
Status last verified
Oct 2021
First submitted
9 Feb 2021
Last updated
2 Nov 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Ultra sound guided nerve block and Usual infiltration in people with Inguinal Hernia, run by Imam Abdulrahman Bin Faisal University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Nasser M Amer (00966 53 865 9290, nmamer@iau.edu.sa), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Scale (from 1 to 10) 1 is the minimum and 10 the maximum pain severity. (time frame: Day 1 postoperative.). The study lists 20 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in